John Snisarenko is Chief Commercial Officer of Oyster Point Pharma, Inc.. Currently has a direct ownership of 30,322 shares of OYST, which is worth approximately $0. The most recent transaction as insider was on Jan 09, 2022, when has been sold 12,100 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.3K
0% 3M change
0% 12M change
Total Value Held $0

John Snisarenko Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2022
BUY
Grant, award, or other acquisition
-
12,100 Added 28.52%
30,322 Common Stock
Jan 29 2021
BUY
Grant, award, or other acquisition
-
11,222 Added 38.11%
18,222 Common Stock

Also insider at

ALIM
ALIMERA SCIENCES INC Healthcare
JS

John Snisarenko

Chief Commercial Officer
Princeton, NJ

Track Institutional and Insider Activities on OYST

Follow Oyster Point Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OYST shares.

Notify only if

Insider Trading

Get notified when an Oyster Point Pharma, Inc. insider buys or sells OYST shares.

Notify only if

News

Receive news related to Oyster Point Pharma, Inc.

Track Activities on OYST